VANGUARD GROUP INC 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 5:39 pm Sale | 2026-03-13 | 13G | CORE LABORATORIES INC CLB | VANGUARD GROUP INC | 0 0.000% | -3,047,390 (Position Closed) | Filing |
| 2025-10-30 2:56 pm Sale | 2025-09-30 | 13G | CORE LABORATORIES INC CLB | VANGUARD GROUP INC | 3,047,390 6.490% | -1,431,700 (-31.96%) | Filing |
| 2025-07-29 11:22 am Sale | 2025-06-30 | 13G | CORE LABORATORIES INC CLB | VANGUARD GROUP INC | 4,479,090 9.550% | -885,243 (-16.50%) | Filing |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | CORE LABORATORIES INC CLB | VANGUARD GROUP INC | 5,364,333 11.480% | 98,476 (+1.87%) | Filing |
| 2023-06-09 2:15 pm Purchase | 2023-05-31 | 13G | CORE LABORATORIES INC CLB | VANGUARD GROUP INC | 5,265,857 11.280% | 5,265,857 (New Position) | Filing |